HomeInsightsStock Comparison

Alivus Life Sciences Ltd vs Jeena Sikho Lifecare Ltd Stock Comparison

Alivus Life Sciences Ltd vs Jeena Sikho Lifecare Ltd Stock Comparison

Last Updated on: Jun 24, 2025

Key Highlights

  • The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 993 as of 24 Jun 11:36.
  • The P/E Ratio of Alivus Life Sciences Ltd is 0 as of March 2022 .The P/E Ratio of Jeena Sikho Lifecare Ltd is 0 as of March 2022.
  • The Market Cap of Alivus Life Sciences Ltd is ₹ 0 crore as of March 2022 .The Market Cap of Jeena Sikho Lifecare Ltd is ₹ 0 crore as of March 2022.
  • The revenue of Alivus Life Sciences Ltd for the Mar '25 is ₹ 659.63 crore as compare to the Dec '24 revenue of ₹ 652.3 crore. This represent the growth of 1.12% The revenue of Jeena Sikho Lifecare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Alivus Life Sciences Ltd for the Mar '25 is ₹ 208.52 crore as compare to the Dec '24 ebitda of ₹ 200.76 crore. This represent the growth of 3.87% The ebitda of Jeena Sikho Lifecare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Alivus Life Sciences Ltd changed from ₹ 135.45 crore to ₹ 141.87 crore over 8 quarters. This represents a CAGR of 2.34% The net profit of Jeena Sikho Lifecare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 58.56 % on March 2024 . This represents a CAGR of -1.60% over 3 yearsThe Dividend Payout of Jeena Sikho Lifecare Ltd changed from 8.19 % on March 2023 to 17.24 % on March 2024 . This represents a CAGR of 45.09% over 2 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alivus Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

About Jeena Sikho Lifecare Ltd

  • Jeena Sikho Lifecare Limited was originally incorporated as a Private Limited Company in the name and style of 'Jeena Sikho Lifecare Private Limited' dated May 29, 2017 issued by the Registrar of Companies, Delhi.
  • Subsequently, the Company got converted into Public Limited Company and the name of the Company was changed to 'Jeena Sikho Lifecare Limited' and a fresh Certificate of Incorporation dated July 05, 2021, was issued by Registrar of Companies, Delhi. Jeena Sikho Lifecare Limited is a renowned Ayurvedic healthcare company headquartered in Zirakpur, Punjab.
  • The Company is one of the leading ayurvedic healthcare system providers in India.
  • The Company is selling more than 250 Herbal/ Ayurvedic products.
  • The Company conducts various health checkup camps, yoga sessions to make people aware of their health problems as well.

Alivus Life Sciences Ltd News Hub

News

Board of Alivus Life Sciences recommends final dividend

Alivus Life Sciences announced that the Board of Directors of the Company at its meeting h...

Read more

16 May 2025 09:27

News

Alivus Life Sciences to hold board meeting

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

09 May 2025 10:57

News

Alivus Life Sciences allots 92,096 equity shares under ESOS

Alivus Life Sciences has allotted 92,096 equity shares under ESOS on 30 April 2025. Conseq...

Read more

30 Apr 2025 19:38

News

Alivus Life jumps after Q3 PAT climbs 15% YoY to Rs 137 cr

Profit before tax (PBT) climbed 15.22% YoY to Rs 185.14 crore in Q3 FY25. For Q3FY25, EBIT...

Read more

23 Jan 2025 15:01

News

Alivus Life Sciences Ltd leads gainers in 'A' group

Avantel Ltd, Sunteck Realty Ltd, Spandana Sphoorty Financial Ltd and Jai Corp Ltd are amon...

Read more

21 Jan 2025 12:00

News

Glenmark Life Sciences renamed as Alivus Life Sciences

Glenmark Life Sciences announced its change of identity to Alivus Life Sciences, marking a...

Read more

20 Jan 2025 10:18

Jeena Sikho Lifecare Ltd News Hub

News

Jeena Sikho Lifecare revises Final Dividend

Jeena Sikho Lifecare post effectiveness of the split/ sub-division of every 1 (One) equity...

Read more

16 Jun 2025 10:19

News

Board of Jeena Sikho Lifecare recommends final dividend

Jeena Sikho Lifecare announced that the Board of Directors of the Company at its meeting h...

Read more

16 May 2025 16:28

News

Jeena Sikho Lifecare announces board meeting date

Jeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 16 Ma...

Read more

14 May 2025 16:33

News

Jeena Sikho Lifecare declare Quarterly Result

Jeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 21 Ap...

Read more

16 Apr 2025 13:57

News

Jeena Sikho Lifecare to announce Quarterly Result

Jeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 11 No...

Read more

06 Nov 2024 12:54

News

Jeena Sikho Lifecare announces board meeting date

Jeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 3 Oct...

Read more

24 Sep 2024 17:45

SWOT Analysis Of Jeena Sikho Lifecare Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Jeena Sikho Lifecare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alivus Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alivus Life Sciences Ltd and Jeena Sikho Lifecare Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or Jeena Sikho Lifecare Ltd?

Market cap of Alivus Life Sciences Ltd is 12,224 Cr while Market cap of Jeena Sikho Lifecare Ltd is 5,275 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Jeena Sikho Lifecare Ltd?

The stock performance of Alivus Life Sciences Ltd and Jeena Sikho Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and Jeena Sikho Lifecare Ltd?

As of June 24, 2025, the Alivus Life Sciences Ltd stock price is INR ₹996.85. On the other hand, Jeena Sikho Lifecare Ltd stock price is INR ₹424.45.

How do dividend payouts of Alivus Life Sciences Ltd and Jeena Sikho Lifecare Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and Jeena Sikho Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions